Status:
UNKNOWN
Effectiveness of Coping Strategies on the Control of Chronic Non-Cancer Pain and Quality of Life (CNCP_CopQol)
Lead Sponsor:
Hospital San Juan de Dios del Aljarafe de Sevilla
Collaborating Sponsors:
University of Seville
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Conditions:
Chronic Pain
Musculoskeletal Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
* Introduction and objectives: Non-pharmacological interventions in patients with musculoskeletal chronic non-cancer pain (mCNCP) are positioning themselves as an essential pillar in treatment along w...
Detailed Description
1. BACKGROUND AND RATIONALE Many people with mCNCP experience stress, fear and depression. These emotions, mental states and their associated behaviours often act as aggravating factors, amplifyin...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- People over the age of 18.
- People with mCNCP served for this reason in the Primary Care Centres depend on Hospital San Juan de Dios del Aljarafe, who follow regular specific treatment on the WHO analgesic scale and who have accepted, after information and informed consent signature, their participation in this study.
- Able to read and write Spanish.
- EXCLUSION CRITERIA:
- Patients who have received interventional analgesic treatment in the year for the current disease.
- Have followed program or maintain out-of-hospital therapy similar to the one this study focuses on.
- Have had surgery or been on a waiting list during the study.
- Severe or decompensated systemic disease.
- Active cancer disease.
- Psychiatric pathology, epilepsy or cognitive impairment.
- Abuse drug addiction.
- Accidents or new Injuries that may increase the perception of pain during the study.
- Labor litigation due to pain.
- Language barrier.
- LOSS CRITERIA:
- Voluntary abandonment of the study.
- Absence of one or more workshop sessions
- Partial or complete loss of telephone follow-up.
- Incomplete data collection.
- Exitus.
- Present any suspicious symptoms of COVID-19 disease collected by phone call the day before the workshop or communicate direct contact with a person infected in the previous days.
Exclusion
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04696107
Start Date
April 1 2021
End Date
December 31 2022
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital San Juan de Dios del Aljarafe
Bormujos, Sevilla, Spain, 41930